| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $108K | -64.0% |
| Cost of Revenue | $71K | -74.0% |
| Gross Profit | $37K | +37.0% |
| R&D Expense | $157K | +5133.3% |
| SG&A Expense | $905K | +9.6% |
| Operating Income | -$1.0M | -27.8% |
| Net Income | -$985K | -35.7% |
| EPS (Basic) | -$0.02 | +0.0% |
| EPS (Diluted) | -$0.02 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.3M | -44.9% |
| Accounts Receivable | $37K | — |
| Current Assets | $1.4M | -41.6% |
| Total Assets | $1.6M | -34.4% |
| Current Liabilities | $345K | +10.9% |
| Total Liabilities | $776K | +15.6% |
| Stockholders' Equity | $851K | -52.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$918K | -67.5% |
| Capital Expenditures | $77K | +327.8% |
| Investing Cash Flow | -$77K | -327.8% |
| Free Cash Flow | -$995K | -75.8% |
| +0.0% |